SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates

Abstract The effects of heterogeneous infection, vaccination and boosting histories prior to and during pregnancy have not been extensively studied and are likely important for protection of neonates. We measure levels of spike binding antibodies in 4600 patients and their neonates with different va...

Full description

Bibliographic Details
Main Authors: Elisabeth A. Murphy, Camila Guzman-Cardozo, Ashley C. Sukhu, Debby J. Parks, Malavika Prabhu, Iman Mohammed, Magdalena Jurkiewicz, Thomas J. Ketas, Sunidhi Singh, Marie Canis, Eva Bednarski, Alexis Hollingsworth, Embree M. Thompson, Dorothy Eng, Paul D. Bieniasz, Laura E. Riley, Theodora Hatziioannou, Yawei J. Yang
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-39989-y
_version_ 1797743990742712320
author Elisabeth A. Murphy
Camila Guzman-Cardozo
Ashley C. Sukhu
Debby J. Parks
Malavika Prabhu
Iman Mohammed
Magdalena Jurkiewicz
Thomas J. Ketas
Sunidhi Singh
Marie Canis
Eva Bednarski
Alexis Hollingsworth
Embree M. Thompson
Dorothy Eng
Paul D. Bieniasz
Laura E. Riley
Theodora Hatziioannou
Yawei J. Yang
author_facet Elisabeth A. Murphy
Camila Guzman-Cardozo
Ashley C. Sukhu
Debby J. Parks
Malavika Prabhu
Iman Mohammed
Magdalena Jurkiewicz
Thomas J. Ketas
Sunidhi Singh
Marie Canis
Eva Bednarski
Alexis Hollingsworth
Embree M. Thompson
Dorothy Eng
Paul D. Bieniasz
Laura E. Riley
Theodora Hatziioannou
Yawei J. Yang
author_sort Elisabeth A. Murphy
collection DOAJ
description Abstract The effects of heterogeneous infection, vaccination and boosting histories prior to and during pregnancy have not been extensively studied and are likely important for protection of neonates. We measure levels of spike binding antibodies in 4600 patients and their neonates with different vaccination statuses, with and without history of SARS-CoV-2 infection. We investigate neutralizing antibody activity against different SARS-CoV-2 variant pseudotypes in a subset of 259 patients and determined correlation between IgG levels and variant neutralizing activity. We further study the ability of maternal antibody and neutralizing measurements to predict neutralizing antibody activity in the umbilical cord blood of neonates. In this work, we show SARS-CoV-2 vaccination and boosting, especially in the setting of previous infection, leads to significant increases in antibody levels and neutralizing activity even against the recent omicron BA.1 and BA.5 variants in both pregnant patients and their neonates.
first_indexed 2024-03-12T15:03:26Z
format Article
id doaj.art-6d381e7c295f4d94bdcb49c6735ccd37
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-12T15:03:26Z
publishDate 2023-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-6d381e7c295f4d94bdcb49c6735ccd372023-08-13T11:16:31ZengNature PortfolioNature Communications2041-17232023-08-0114111010.1038/s41467-023-39989-ySARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonatesElisabeth A. Murphy0Camila Guzman-Cardozo1Ashley C. Sukhu2Debby J. Parks3Malavika Prabhu4Iman Mohammed5Magdalena Jurkiewicz6Thomas J. Ketas7Sunidhi Singh8Marie Canis9Eva Bednarski10Alexis Hollingsworth11Embree M. Thompson12Dorothy Eng13Paul D. Bieniasz14Laura E. Riley15Theodora Hatziioannou16Yawei J. Yang17Department of Pathology and Laboratory Medicine, Weill Cornell MedicineLaboratory of Retrovirology, The Rockefeller UniversityDepartment of Pathology and Laboratory Medicine, New York Presbyterian/Weill Cornell Medical CenterLaboratory of Retrovirology, The Rockefeller UniversityDepartment of Obstetrics & Gynecology, Weill Cornell MedicineDepartment of Obstetrics & Gynecology, Weill Cornell MedicineDepartment of Pathology and Laboratory Medicine, Weill Cornell MedicineDepartment of Microbiology and Immunology, Weill Cornell MedicineWeill Cornell MedicineLaboratory of Retrovirology, The Rockefeller UniversityLaboratory of Retrovirology, The Rockefeller UniversityWeill Cornell MedicineWeill Cornell MedicineDepartment of Pathology and Laboratory Medicine, New York Presbyterian/Weill Cornell Medical CenterLaboratory of Retrovirology, The Rockefeller UniversityDepartment of Obstetrics & Gynecology, Weill Cornell MedicineLaboratory of Retrovirology, The Rockefeller UniversityDepartment of Pathology and Laboratory Medicine, Weill Cornell MedicineAbstract The effects of heterogeneous infection, vaccination and boosting histories prior to and during pregnancy have not been extensively studied and are likely important for protection of neonates. We measure levels of spike binding antibodies in 4600 patients and their neonates with different vaccination statuses, with and without history of SARS-CoV-2 infection. We investigate neutralizing antibody activity against different SARS-CoV-2 variant pseudotypes in a subset of 259 patients and determined correlation between IgG levels and variant neutralizing activity. We further study the ability of maternal antibody and neutralizing measurements to predict neutralizing antibody activity in the umbilical cord blood of neonates. In this work, we show SARS-CoV-2 vaccination and boosting, especially in the setting of previous infection, leads to significant increases in antibody levels and neutralizing activity even against the recent omicron BA.1 and BA.5 variants in both pregnant patients and their neonates.https://doi.org/10.1038/s41467-023-39989-y
spellingShingle Elisabeth A. Murphy
Camila Guzman-Cardozo
Ashley C. Sukhu
Debby J. Parks
Malavika Prabhu
Iman Mohammed
Magdalena Jurkiewicz
Thomas J. Ketas
Sunidhi Singh
Marie Canis
Eva Bednarski
Alexis Hollingsworth
Embree M. Thompson
Dorothy Eng
Paul D. Bieniasz
Laura E. Riley
Theodora Hatziioannou
Yawei J. Yang
SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
Nature Communications
title SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
title_full SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
title_fullStr SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
title_full_unstemmed SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
title_short SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
title_sort sars cov 2 vaccination booster and infection in pregnant population enhances passive immunity in neonates
url https://doi.org/10.1038/s41467-023-39989-y
work_keys_str_mv AT elisabethamurphy sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT camilaguzmancardozo sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT ashleycsukhu sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT debbyjparks sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT malavikaprabhu sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT imanmohammed sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT magdalenajurkiewicz sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT thomasjketas sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT sunidhisingh sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT mariecanis sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT evabednarski sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT alexishollingsworth sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT embreemthompson sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT dorothyeng sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT pauldbieniasz sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT lauraeriley sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT theodorahatziioannou sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates
AT yaweijyang sarscov2vaccinationboosterandinfectioninpregnantpopulationenhancespassiveimmunityinneonates